Our Views Articles, views and insights from the ADAMAS team. ADAMAS Consulting is delighted to announce the opening of our new office located in San Diego, California ADAMAS Consulting is delighted to announce the opening of our new office located in San Diego, California. ADAMAS brings 23 years of thought... KRIs and QTLs, Simplified It has been nearly four years since the release of ICH E6 (R2) in November 2016, however a recent poll on status of... Superior Vendor Compliance with ADAMAS Did you know that ADAMAS provides an enhanced level of compliance that you may not find when selecting other contract QA organisations or... Second Wave, Second Strain Could a second, potentially more contagious wave, of COVID-19 bring further disruption to travel and clinical trial activities? Is it possible to meet... Do you protect your staff or your Clinical Trial? It’s a tough choice – new drugs for patients or the health and safety of your valued staff? With ADAMAS Consulting, you do... FDA Announces the Retirement of the MedWatch to Manufacturers Program The U.S. Food and Drug Administration has announced the retirement of the MedWatch to Manufacturer Program (MMP) as of 31st July 2020. The... Load More Loading More... You’ve reached the end of the list
ADAMAS Consulting is delighted to announce the opening of our new office located in San Diego, California ADAMAS Consulting is delighted to announce the opening of our new office located in San Diego, California. ADAMAS brings 23 years of thought...
KRIs and QTLs, Simplified It has been nearly four years since the release of ICH E6 (R2) in November 2016, however a recent poll on status of...
Superior Vendor Compliance with ADAMAS Did you know that ADAMAS provides an enhanced level of compliance that you may not find when selecting other contract QA organisations or...
Second Wave, Second Strain Could a second, potentially more contagious wave, of COVID-19 bring further disruption to travel and clinical trial activities? Is it possible to meet...
Do you protect your staff or your Clinical Trial? It’s a tough choice – new drugs for patients or the health and safety of your valued staff? With ADAMAS Consulting, you do...
FDA Announces the Retirement of the MedWatch to Manufacturers Program The U.S. Food and Drug Administration has announced the retirement of the MedWatch to Manufacturer Program (MMP) as of 31st July 2020. The...
